Genetic and Immunological Backgrounds in Advanced NSCLC Patients Treated with Immunotherapy - NGS and Flow Cytometry Analysis

被引：0
|
作者：
Krzyzanowska, N. [1 ]
Nicos, M. [1 ]
Wojas-Krawczyk, K. [1 ]
Krawczyk, P. [1 ]
Chmielewska, I. [1 ]
Jankowski, T. [1 ]
Kucharczyk, T. [1 ]
Wojcik-Superczynska, M. [1 ]
Sroka-Bartnicka, A. [1 ]
Stokowy, T. [2 ]
Milanowski, J. [1 ]
机构：
[1] Med Univ Lublin, Lublin, Poland
[2] Univ Bergen, Bergen, Norway
来源：
JOURNAL OF THORACIC ONCOLOGY | 2024年 / 19卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P3.06E.04
引用
收藏
页码：S330 / S331
页数：2
相关论文
共 50 条
  • [31] Molecular Characterization by Next-Generation Sequencing (NGS) of Patients with Non-Small Cell Lung Cancer (NSCLC) Treated with Immunotherapy
    Cruz Castellanos, P.
    Rosas Alonso, R.
    Ozaez, I.
    Hernandez, I.
    Losantos, I.
    Gutierrez Sainz, L.
    Higuera Gomez, O.
    Rodriguez Antolin, C.
    Esteban Rodriguez, I.
    Ibanez de Caceres, I.
    de Castro Carpeno, J.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S558 - S558
  • [32] Clinical feasibility of NGS liquid biopsy analysis in NSCLC patients
    Papadopoulou, Eirini
    Tsoulos, Nikolaos
    Tsantikidi, Katerina
    Metaxa-Mariatou, Vasiliki
    Stamou, Pinelopi Eleftheria
    Kladi-Skandali, Athina
    Kapeni, Evgenia
    Tsaousis, Georgios
    Pentheroudakis, George
    Petrakis, Dimitrios
    Lampropoulou, Dimitra Ioanna
    Aravantinos, Gerasimos
    Varthalitis, Ioannis
    Kesisis, George
    Boukovinas, Ioannis
    Papakotoulas, Pavlos
    Katirtzoglou, Nikolaos
    Athanasiadis, Elias
    Stavridi, Flora
    Christodoulou, Christos
    Koumarianou, Anna
    Eralp, Yesim
    Nasioulas, George
    PLOS ONE, 2019, 14 (12):
  • [33] Full Spectrum Flow Cytometry-powered Analysis of PBMC as Biomarkers for Immunotherapy in NSCLC with EGFR-TKI Resistance
    Zhou, J.
    Su, C.
    JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (11) : S312 - S313
  • [34] Immune gene expression and bayesian network analysis in advanced non small cell lung cancer (NSCLC) patients treated with immunotherapy.
    Baglivo, Sara
    Bianconi, Fortunato
    Tofanetti, Francesca Romana
    Ricciuti, Biagio
    Pistola, Lorenza
    Siggillino, Annamaria
    Reda, Maria Sole
    Mencaroni, Clelia
    Curra, Maria Francesca
    Teti, Valeria
    Metro, Giulio
    Bellezza, Guido
    Minotti, Vincenzo
    Roila, Fausto
    Ludovini, Vienna
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [35] Scanning flow Cytometry for advanced analysis of cells
    Maltsev, VP
    CYTOMETRY, 2002, : 124 - 125
  • [36] Artificial intelligence to improve selection for NSCLC patients treated with immunotherapy
    Prelaj, Arsela
    Boeri, Mattia
    Robuschi, Alessandro
    Proto, Claudia
    Lo Russo, Giuseppe
    Ferrara, Roberto
    Galli, Giulia
    De Toma, Alessandro
    Brambilla, Marta
    Occhipinti, Mario
    Manglaviti, Sara
    Labianca, Alice
    Beninato, Teresa
    Bini, Marta
    Mensah, Mavis
    Ganzinelli, Monica
    Zilembo, Nicoletta
    De Braud, Filippo
    Sozzi, Gabriella
    Restelli, Marcello
    Pedrocchi, Alessandra
    Garassino, Marina Chiara
    Trovo, Francesco
    CLINICAL CANCER RESEARCH, 2021, 27 (05)
  • [37] Blood cytokine changes in patients with advanced NSCLC receiving immunotherapy
    Schindler, H. L.
    Lusky, F.
    Gaissmaier, L.
    Daniello, L.
    Elshiaty, M.
    Bozorgmehr, F.
    Kuon, J.
    Shah, R.
    Schneider, M.
    Eichhorn, F.
    Baum, P.
    Angeles, A.
    Janke, F.
    Kriegsmann, M.
    Kazdal, D.
    Stenzinger, A.
    Sultmann, H.
    Thomas, M.
    Christopoulos, P.
    ANNALS OF ONCOLOGY, 2022, 33 : S61 - S62
  • [38] A highly predictive blood-radiomics classifier in advanced NSCLC treated with immunotherapy
    Mazzaschi, G.
    Scandino, R.
    Milanese, G.
    Pavone, C.
    Maurizio, B.
    Silva, M.
    Ledda, R.
    Minari, R.
    Trentini, F.
    Buti, S.
    Bordi, P.
    Leonetti, A.
    Quaini, F.
    Sverzellati, N.
    Romanel, A.
    Tiseo, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S1027 - S1027
  • [39] Immunotherapy (I) for Advanced, Pre-Treated, Non-Squamous NSCLC (APNS-NSCLC). Preliminary Data of a Pooled Analysis
    Tassinari, D.
    Cherubini, C.
    Pilati, M.
    Papi, M.
    Nicoletti, S. V. L.
    Agli, L. A. Lazzari
    Landi, L.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S464 - S464
  • [40] Prognostic factors for survival in NSCLC treated with immunotherapy: An institutional analysis
    Huang, Judy
    Khullar, Rohit
    Bhattacharya, Moinak
    Keresztes, Roger
    Prasanna, Prateek
    Sher, Amna Falak
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
12345